Researchers recently unveiled AlphaGenome, a deep learning model from Google DeepMind capable of predicting how genetic variants in non-coding DNA influence gene regulation and disease processes — a long-standing challenge in genomics research. This advancement may accelerate discovery of gene-disease links and inform new therapeutic strategies.